IQVIA’s AI & Technology Solutions (ATS) organization is seeking a Principal Enterprise Architect – Mergers & Acquisitions to define, govern, and evolve enterprise‑wide architecture strategy, standards, and roadmaps across a large, global technology landscape.
This role sits within the Architecture & Standards (A&S) group and partners closely with Corporate Development, the M&A IT Office, Enterprise Technology Solutions, Information Security, Data Privacy, Legal/IP, Finance, and Business Units to support IQVIA’s strong M&A strategy—covering active integrations, backlog acquisitions, and future deal pipeline.
You will serve as the architectural authority driving the evolution toward AI‑agent‑driven M&A IT integration, transforming complex discovery, risk assessment, and application rationalization processes into a high‑velocity, automated and scalable capability. This role requires deep, hands‑on experience across pre‑close and post‑close M&A integrations.
Key ResponsibilitiesThe Principal Enterprise Architect – M&A is a senior, highly specialized role responsible for leading all architectural dimensions of IQVIA’s mergers and acquisitions initiatives.
You will:
Serve as a senior architectural authority during:
- Deal evaluation and pre‑LOI assessments
- Technology due diligence
- Integration planning and execution
- Post‑close stabilization and optimization
Define and govern enterprise architecture strategies that:
- Enable rapid, scalable M&A integrations
- Reduce technology risk and complexity
- Maximize value realization and synergy targets
Lead technology landscape assessments, including:
- Current‑state evaluation of infrastructure, applications, and data
- Identification of gaps, risks, and compliance issues
- Architectural boundary definition for carve‑outs and divestitures
Design integration and migration strategies, roadmaps, and target‑state architectures
Partner with senior leaders to:
- Influence technology investment and integration decisions
- Communicate architectural risks and opportunities to executive and C‑suite stakeholders
Drive application portfolio rationalization, standardization, and system retirement
Ensure alignment with enterprise security, privacy, and compliance standards (e.g., NIST, ISO)
Act as a trusted advisor to:
- Corporate Development
- CIO and CISO organizations
- Business and technology executives
- Measurably reduce the time required to produce M&A technology assessments through improved playbooks and reusable tooling
- Drive application rationalization initiatives that deliver post‑merger synergy targets
- Establish scalable, repeatable architecture patterns for M&A integrations
- Mentor and develop at least two senior architects in M&A‑specific architecture practices
15+ years of experience in enterprise or solution architecture roles
4+ years leading technology due diligence and/or integration architecture in M&A environments
Proven experience across the full M&A lifecycle, including:
- Pre‑LOI screening
- Due diligence
- Day 1 readiness
- Post‑merger integration and stabilization
Deep expertise in:
- Enterprise architecture frameworks
- Application portfolio management
- Integration and migration strategies
Strong working knowledge of:
- Cloud platforms (AWS, Azure, GCP)
- Hybrid and distributed integration patterns
- Data architecture and governance
Experience with carve‑outs and divestitures, including Transition Service Agreements (TSAs)
Solid understanding of cybersecurity and risk assessment frameworks (NIST, ISO 27001, SOC 2) as applied to M&A
Exceptional executive communication and influence skills, with the ability to present architectural findings and risks to senior and board‑level audiences
Demonstrated ability to partner effectively with senior business, technology, and product leaders to drive adoption of standards‑based architectures at scale
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, status as a protected veteran, or any other status protected by applicable law. https://jobs.iqvia.com/eoe
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.
The potential base pay range for this role, when annualized, is $118,100.00 - $328,800.00. The actual base pay offered may vary based on a number of factors including job-related qualifications such as knowledge, skills, education, and experience; location; and/or schedule (full or part-time). Dependent on the position offered, incentive plans, bonuses, and/or other forms of compensation may be offered, in addition to a range of health and welfare and/or other benefits.Top Skills
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories



